Omalizumab: a new add‐on therapy for severe asthma
Journal article published in 2006 by
Chris Corrigan 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Omalizumab is a new injectable antibody for use in patients with severe asthma who are poorly controlled on existing therapies. Dr Corrigan describes the clinical trial results of its efficacy and side-effects, and explains how it is administered. Copyright © 2006 Wiley Interface Ltd